BKNG: Shorts Keep Retreating as Wells Fargo Trims Into Earnings

Options positioning offers a mild counterpoint to that cautious reading. The put/call ratio has actually drifted lower over the past week to 0.84, running slightly below its 20-day average of 0.86 and at a z-score of negative 1.3. That means options traders are not reaching heavily for downside protection despite the stock's sharp decline. The overall positioning picture reads more like a gradual de-risking of a large short book than any kind of bullish re-engagement: shorts are exiting, but options buyers are not replacing them with put demand.

The Street's direction has been clear enough, though the distance between targets and the current price is growing awkward. The consensus remains a buy, with 24 buy ratings and a mean price target of $237.40, implying roughly 50% upside from $157.63. But targets have been coming down. Wells Fargo this week cut its target from $220 to $190, maintaining its Equal-Weight rating, a signal that at least one bellwether firm sees the gap between price and fair value as narrower than the consensus implies. Truist trimmed from $242 to $216 last week, also keeping its Buy. Morgan Stanley assumed coverage at Overweight with a $230 target in mid-September. Against that, Evercore ISI raised to $270 in late August after the Q2 print, and UBS lifted to $274. The net message is a bullish consensus under moderate revision pressure. On valuation, the trailing P/E has moved down to 13.2x, a level the bear case characterises as cheap at face value but reflecting real risks: EU regulatory exposure, softening flight-ticket growth, and the structural question of whether AI-driven travel tools eventually erode the OTA's role as intermediary. The bull case counters with mid-30s EBITDA margins, 90% plus free cash flow conversion, and Connected Trip as a still-underpenetrated growth layer.

Insider activity over the past 90 days has been one-directional. The company's filings show net sales of approximately 83,000 shares worth around $17.2 million across that period, with the General Counsel accounting for the bulk of it in August at prices between $205 and $213. Importantly, every disclosed trade carried a 10b5-1 plan designation, meaning they were pre-scheduled rather than reactive to the recent slide. There are no open-market purchases on record in the window, and the selling took place at prices now well above the current level.

With Q3 earnings scheduled for October 29, three weeks out, the question that will define the next move is whether management's guidance for full-year gross bookings and adjusted EBITDA growing in the high single digits holds, or whether the tape's near-20% decline over one month has already priced in a downgrade to that outlook. The last print, in August, produced a 7.4% next-day gain. The one before that saw a 4.2% one-day loss. The direction of the upcoming print rather than the level of short interest is now the primary variable worth watching.